1/1

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c – Translating Evidence into Practice

figure
posted on 15.09.2020 by Amar Ali, Steve Bain, Debbie Hicks, Phillip Newland Jones, Dipesh C. Patel, Marc Evans, Kevin Fernando, June James, Nicola Milne, Adie Viljoe, John Wilding, As part of The Improving Diabetes Steering Committee

The above summary slide and prescribing tool represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Exports